Company / R&D per Share
SI-BONE, Inc. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.41
FY2025
5-year range
$0.38 / $0.43
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
#87 of 103
Health Care
What the data says
SI-BONE, Inc.'s r&d per share of $0.41 is lower than 84% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 9 years, ranging from $0.30 in FY2019 to $1.59 in FY2017.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of +2.0%.
Declined from $0.43 to $0.41 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 103This company $0.41 Sector average $2.13
▼
-80.6% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 1.9% year-over-year.
- Ranks #87 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2017.
- Lowest r&d per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | +1.9% |
| FY2024 | $0.41 | -5.9% |
| FY2023 | $0.43 | +6.9% |
| FY2022 | $0.40 | +6.0% |
| FY2021 | $0.38 | +1.6% |
| FY2020 | $0.38 | +26.3% |
| FY2019 | $0.30 | -80.0% |
| FY2018 | $1.49 | -6.2% |
| FY2017 | $1.59 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026